Clene Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Clene Inc. (CLNN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 1.41 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-14
- Clene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was -6.22K shares, a 172.24% decline year-over-year.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 213.00 shares, a 94.17% decline year-over-year.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 11.32K shares.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 583.00 shares, a 99.59% decline year-over-year.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 5.89K shares, a 71.81% decline from fiscal 2024.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 20.90K shares, a 95.53% decline from fiscal 2023.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 467.11K shares, a 62.81% increase from fiscal 2022.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 286.91K shares, a 214.45% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.41K shares 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | -6.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -6.01K shares derived: sum of 2 quarters · filed 2026-03-17 | 5.31K shares derived: sum of 3 quarters · filed 2026-03-17 | 5.89K shares 10-K · filed 2026-03-17 |
| 2025-09-30 | 213.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 11.53K shares derived: sum of 2 quarters · filed 2025-11-13 | 12.12K shares 10-Q · filed 2025-11-13 | 20.73K shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 11.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 11.90K shares 10-Q · filed 2025-08-14 | 20.52K shares derived: sum of 3 quarters · filed 2025-08-14 | 24.17K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 583.00 shares 10-Q · filed 2025-05-07 | 9.20K shares derived: sum of 2 quarters · filed 2025-05-07 | 12.85K shares derived: sum of 3 quarters · filed 2025-05-07 | -119.64K shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | 8.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 12.27K shares derived: sum of 2 quarters · filed 2025-03-24 | -120.22K shares derived: sum of 3 quarters · filed 2025-03-24 | 20.90K shares 10-K · filed 2025-03-24 |
| 2024-09-30 | 3.65K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -128.84K shares derived: sum of 2 quarters · filed 2024-11-13 | 12.29K shares 10-Q · filed 2024-11-13 | 46.13K shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | -132.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 8.64K shares 10-Q · filed 2024-08-07 | 42.48K shares derived: sum of 3 quarters · filed 2024-08-07 | 81.14K shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 141.12K shares 10-Q · filed 2024-05-08 | 174.97K shares derived: sum of 2 quarters · filed 2024-05-08 | 213.62K shares derived: sum of 3 quarters · filed 2024-05-08 | 475.91K shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 33.85K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 72.50K shares derived: sum of 2 quarters · filed 2024-03-13 | 334.78K shares derived: sum of 3 quarters · filed 2024-03-13 | 467.11K shares 10-K · filed 2024-03-13 |
| 2023-09-30 | 38.65K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 300.94K shares derived: sum of 2 quarters · filed 2023-11-07 | 433.26K shares 10-Q · filed 2023-11-07 | 677.75K shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 262.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 394.61K shares 10-Q · filed 2023-08-14 | 639.10K shares derived: sum of 3 quarters · filed 2023-08-14 | 646.24K shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 132.32K shares 10-Q · filed 2023-05-12 | 376.81K shares derived: sum of 2 quarters · filed 2023-05-12 | 383.96K shares derived: sum of 3 quarters · filed 2023-05-12 | 410.93K shares derived: sum of 4 quarters · filed 2023-05-12 |
| 2022-12-31 | 244.49K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 251.63K shares derived: sum of 2 quarters · filed 2023-03-13 | 278.60K shares derived: sum of 3 quarters · filed 2023-03-13 | 286.91K shares 10-K · filed 2023-03-13 |
| 2022-09-30 | 7.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 34.12K shares derived: sum of 2 quarters · filed 2022-11-07 | 42.42K shares 10-Q · filed 2022-11-07 | -80.00 shares derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | 26.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 35.28K shares 10-Q · filed 2022-08-15 | -7.22K shares derived: sum of 3 quarters · filed 2022-08-15 | 71.94K shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 8.30K shares 10-Q · filed 2022-05-09 | -34.20K shares derived: sum of 2 quarters · filed 2022-05-09 | 44.97K shares derived: sum of 3 quarters · filed 2022-05-09 | |
| 2021-12-31 | -42.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | 36.66K shares derived: sum of 2 quarters · filed 2022-03-11 | 91.24K shares 10-K · filed 2022-03-11 | |
| 2021-09-30 | 79.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 133.74K shares 10-Q · filed 2021-11-08 | ||
| 2021-06-30 | 54.58K shares 10-Q · filed 2021-08-09 | |||
| 2020-12-31 | 32.90K shares 10-K · filed 2021-03-29 | |||
| 2019-12-31 | 248.76K shares 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |